Earnings, IPO’s, M&A and Private Placements
Week Ending April 6th, 2014
- We love to hear your opinions and comments at firstname.lastname@example.org
- If you like what you read, please share via the SHARE button at the very, very end of this blog
I’ve been struggling in too-much-to-do land, and too-many-high-priorities. My right knee gave out on me, such that I can’t do backstroke and butterfly, and don’t even think about breast stroke. No sooner does my arm reach back to catch the water (in backstroke) than my knee experiences a sharp pain, stopping me dead in the water. Literally. If anyone else has experienced this—please let me know. Best I can tell, orthopedic surgeons have about 15-20 diagnoses in their repertoire. If it isn’t one of those, you’re out of luck.
Currently, I’m pulling on a string from a “Swimmers Knee Injuries” article on Plica Syndrome, which has led me to University of Minnesota’s Steadman Clinic, back to MGH and a fellow named Matt Provencher and then to his PA, Tistia Gaston.
Click on the Company Name for the earnings announcement, and the Company Symbol for the stock chart
A tough week for tech stocks, which continues today. Seems investors are not enamored of Facebook’s (FB: Nasdaq) purchase of Oculus for $2b. Oculus is the developer of the virtual reality headset. Market seers are saying that the market is behaving like it wants to go down, with technology leading the way. Time will tell.
And, yes, times have changed. Newly appointed CEO of Mozilla stepped down just days after his appointment amid a brouhaha of his opposition to gay marriage. My best advice: Like it or not, it’s a fact of life. Get over it.
Click on the Company Name for the S-1 filing and the Company Symbol for the stock chart.
Nine IPO’s priced last week:
Opower (OPWR: Nasdaq) sold 6.1m shares at $19 per share raising $116m at a valuation of $902m. The stock closed the week at $23 per share. We are hoping that our new natural gas provider, a glommed together provider named Liberty Utilities, updates some of their software with Opower. Thus far, we’ve been totally unimpressed.
Opower is a leading provider of cloud-based software to the $2.2 trillion utility industry. Utilities use our software platform to deliver key customer-facing applications that reduce energy demand and improve customer perception of the utility
Five9 (FIVN: Nasdaq) sold 10m shares at $7 per share, raising $70m at a valuation of $322m. The stock closed the week at $7.64. “Five9 is a pioneer and leading provider of cloud software for contact centers.”
Education & China
We are a leading provider of professional education services in China. Our core strength is in IT professional education services, where we are the largest provider in China with a market share of 8.3% as measured by revenues in 2013 according to IDC, a third-party research firm. Since our inception in 2002, we have trained over 130,000 students, cooperated with more than 500 universities and colleges and placed students with approximately 35,000 corporate employers in a variety of industries.
We are a technology company on a mission to automate the buying and selling of advertising. Our Advertising Automation Cloud is a highly scalable software platform that powers and optimizes a leading marketplace for the real time trading of digital advertising between buyers and sellers.
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. We have one of the largest and most comprehensive collections of healthcare information in the world, spanning sales, prescription and promotional data, medical claims, electronic medical records and social media. Our scaled and growing data set contains over 10 petabytes of unique data and over 500 million comprehensive, longitudinal, anonymous patient records (i.e., records that are linked over time for each anonymous individual across healthcare settings). The Company is based in Danbury, CT
We are a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage our broad experience in transdermal and transmucosal delivery systems. Together with our partners, we have successfully developed six marketed products in the prescription drug and consumer markets, and we are the sole commercial supplier of each of those products for our marketing partners
While there’s lots, lots more, it’s time to say goodbye. This week we’re skipping M&A and Private Placements, areas that are near and dear to my heart.
Having not yet figured out how to add time and energy to the day, it’s time to go fetch my MRI’s in Exeter, NH and further prepare for my appointment with the IRS.
Please send me any comments or feedback.
Founder, BlueLake Partners, LLC
SiVal Advisors, LLC
Susan Woods and Vlad Harris
Margaret Johns is the Founder and Chairman of BlueLake Partners, a boutique M&A investment bank based in the Greater Boston Area. Prior to founding BlueLake she was an employee founder and Managing Director at Needham & Company where she worked in Corporate Finance in New York City and headed up its Boston office. She now lives in Londonderry, New Hampshire with her husband, 17 year old step-daughter and three pugs. When she’s not working with clients, FINRA or writing blogs she competes on the Granite State Penguins Masters Swim Team, skis, rides her bike or is out walking her pugs.
Content researched, edited and reviewed on a best efforts basis
We make no claim to being comprehensive in our review, as the contents are companies and topics we, ourselves, find of interest.
This newsletter is currently being proofed by Dave Henshaw, which is much appreciated. Dave is my USMS swimming lane mate, and Granite State Penguin team-mate. He is retired from MIT, where he used to produce and proof their annual financial report. Exactly what we need.